The real-world evidence fusion study is now at full enrollment, allowing all eligible sites to recruit Motus patients, according to the release.
3Spine’s lumbar total joint replacement procedure and Motus device is a new technology, replacing the function of the disc and facet joints through a posterior approach. The technique reconstructs the functional spinal unit, like a hip or knee total joint replacement.
3Spine is still recruiting clinical trial patients for the study but is expecting U.S. approval of Motus by 2025.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
